U.S. Renewable Energy Stock News

NYSE:OUT
NYSE:OUTSpecialized REITs

OUTFRONT Media Refinances Debt And Weighs Dilution Against Growth Story

OUTFRONT Media (NYSE:OUT) has launched a private offering of US$500 million of 6.000% senior notes due 2034. The company plans to use the proceeds to redeem its outstanding senior notes due 2027 ahead of schedule. OUTFRONT Media also filed a new shelf registration to issue common stock for its employee stock ownership plan. OUTFRONT Media is an outdoor advertising company, with assets such as billboards and transit displays that connect brands with commuters and urban audiences. The fresh...
NYSE:NX
NYSE:NXBuilding

Quanex Building Products (NX) Small Q2 Profit Tests Bullish Margin Recovery Narrative

Quanex Building Products (NX) opened Q2 2026 with total revenue of US$462.4 million and basic EPS of US$0.07, while the trailing twelve months show revenue of US$1.9 billion and a basic EPS loss of US$5.65 as the stock trades around US$15.42. The company has seen quarterly revenue move from US$452.5 million in Q2 2025 to US$462.4 million in Q2 2026, with basic EPS shifting from US$0.44 to US$0.07 over the same period. This sets up a picture where top line scale contrasts with pressured...
NYSE:RGA
NYSE:RGAInsurance

RGA’s US$1.5b Equitable Deal Reshapes Life Reinsurance Risk Profile

Reinsurance Group of America (NYSE:RGA) has entered into a $1.5 billion reinsurance agreement with Equitable. The deal covers $32 billion in life insurance policies, transferring a large book of risk to RGA. The transaction is expected to materially expand RGA's business footprint in life reinsurance. For investors watching NYSE:RGA, this agreement comes with the stock recently around $204.96 and multi-year returns of 50.2% over 3 years and 83.1% over 5 years. The size of the Equitable...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Is MannKind (MNKD) Now An Opportunity After A 39% Year To Date Share Price Decline?

If you are wondering whether MannKind at around US$3.40 is a bargain or a value trap, the key question is how its current price compares with what the business might be worth. The stock has had a weak run recently, with the share price down about 9.8% over the last week, 3.4% over the past month, and 39.3% year to date, contributing to a 22.4% decline over the last year and a 16.0% fall over five years. Recent coverage has focused on MannKind's position within the broader Biotechs industry...
NYSE:APAM
NYSE:APAMCapital Markets

Will APAM’s US$186 Billion AUM Update Amid Liquidity Jitters Change Artisan Partners’ Narrative?

In early June 2026, Artisan Partners Asset Management reported preliminary assets under management of US$186.0 billion as of May 31, while broader sector rotation and concerns around redemption limits at peers stirred sentiment across alternative asset managers. This combination of firm-specific asset data and industry-wide liquidity worries has sharpened investor focus on how Artisan Partners’ business mix and expansion plans interact with market conditions. Next, we will examine how the...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Mattel Expands Barbie Momentum Into Films Partnerships And Brick Shop Sets

Mattel (NasdaqGS:MAT) is extending the Barbie movie momentum with a planned Masters of the Universe film. The company is launching a Barbie themed campaign with Dunkin' that brings the brand into food and beverage. Mattel is rolling out Mattel Brick Shop building sets, entering direct competition with established building brands and new product segments. For investors watching NasdaqGS:MAT, this cluster of moves sits at the intersection of toys, entertainment, and consumer partnerships...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Is It Time To Reassess Corebridge Financial (CRBG) After Its Recent Share Price Weakness?

If you are wondering whether Corebridge Financial at around US$26.86 is priced for opportunity or already reflects expectations, the next sections will focus squarely on what the current market price might be implying. The stock has been weak in the short term, with the share price down 0.5% over the last week, down 1.6% over the past month, and down 11.6% year to date, although the three year return stands at 98.5% and the one year return is down 16.6%. Recent coverage has focused on...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Alignment Healthcare’s Fortune 1000 Rise And Leadership Shift For Future Scale

In June 2026, Alignment Healthcare (NasdaqGS:ALHC) was named to the Fortune 1000 list for the second year in a row. The company advanced more than 196 positions and is the only business solely focused on Medicare Advantage in the Healthcare: Insurance and Managed Care category. Founder and CEO John Kao is taking on the additional role of Chairman of the Board, alongside new executive appointments aimed at supporting future scale. For investors tracking Alignment Healthcare at a share price...
NYSE:CRCL
NYSE:CRCLSoftware

Circle (CRCL) Faces New Stablecoin Rivals as EURC Share Climbs and Insiders Trim Stakes

In early June 2026, reports emerged that Visa, Mastercard, Stripe, and potentially Coinbase were developing a new stablecoin platform that could compete with Circle Internet Group’s USDC, while Circle also expanded distribution through partners such as Hyperliquid and Nium and saw several pre-planned insider share sales and tax-related share withholdings. An interesting twist is that as regulatory changes have pushed euro stablecoins to consolidate, Circle’s EURC has grown to around half of...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Itron’s Global Smart Water Push Highlights Grid Edge Software Opportunity

Itron (NasdaqGS:ITRI) announced expanded smart water partnerships with Hunter Water in Australia and the Office d'Equipement Hydraulique de Corse in France. The projects involve broad deployments of advanced water metering and cloud-based management platforms across the two utilities. These initiatives target water conservation, operational efficiency, and reduced non revenue water loss in key international markets. Itron focuses on grid edge solutions for utilities, including smart...
NYSE:P
NYSE:PTech

Everpure (P) Margin Improvement Reinforces Bullish Narratives Despite Q1 Earnings Dip

Everpure (P) opened 2027 with Q1 revenue of US$1.1 billion and basic EPS of US$0.07, alongside trailing twelve month revenue of US$3.9 billion and EPS of US$0.69 that frame the latest quarter in a broader context. Over the past year, the company has seen revenue move from US$3.3 billion to US$3.9 billion and EPS build from US$0.39 to US$0.69, setting the scene for investors to focus on how margins are holding up through this reporting stretch. See our full analysis for Everpure. With the...
NYSE:BLDR
NYSE:BLDRBuilding

Builders FirstSource Board Exit Puts Governance And Execution In Focus

Builders FirstSource Board member Mark A. Alexander resigned from the Board of Directors, effective June 3, 2026. The company stated the decision was due to health reasons and not related to any disagreement over strategy or operations. The change affects the corporate governance structure at Builders FirstSource, which may be relevant for current and prospective shareholders. For investors watching Builders FirstSource (NYSE:BLDR), this Board change comes as the stock trades at $73.64. The...
NasdaqCM:AIRJ
NasdaqCM:AIRJMachinery

Why AirJoule Technologies (AIRJ) Is Up 8.5% After Discounted US$15 Million Direct Equity Raise And What's Next

In late May 2026, AirJoule Technologies Corporation filed a US$14.99 million registered direct follow-on equity offering, issuing 3,658,536 Class A common shares at US$4.10 each, reflecting a US$0.1845 per share discount. This capital raise highlights AirJoule’s continued reliance on equity funding, with the registered direct format likely to influence investor focus on dilution and liquidity. Next, we’ll consider how this registered direct follow-on equity raise, and its implications for...
NasdaqGM:QMCO
NasdaqGM:QMCOTech

Evaluating Quantum (QMCO) After Debt Terminations And Stronger Than Expected Quarterly Guidance

Quantum (QMCO) is drawing attention after a cluster of capital structure moves, including terminating a term loan, canceling secured convertible notes, and moving to end a standby equity purchase agreement, alongside updated fourth quarter revenue guidance. See our latest analysis for Quantum. Quantum's recent debt repayments and positive fourth quarter revenue guidance help explain why the stock has a 90 day share price return of 147.56% and a 1 year total shareholder return of 19.47%, even...
NasdaqGS:LAMR
NasdaqGS:LAMRSpecialized REITs

Assessing Lamar Advertising (LAMR) Valuation As Digital Growth And Dividend Confidence Draw Investor Focus

Lamar Advertising: Dividend Signals and Digital Growth Come Into Focus Recent commentary around Lamar Advertising (LAMR) has centered on management reaffirming full year AFFO guidance and indicating room for a higher dividend if current business trends hold. See our latest analysis for Lamar Advertising. The recent reaffirmation of full year AFFO guidance and commentary on dividend capacity arrives as the stock trades at US$151.42, with a 30 day share price return of 7.28% and a 1 year total...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Is Roper Technologies (ROP) Now Offering Value After A 41.6% Twelve Month Share Price Fall

If you are wondering whether Roper Technologies at around US$332 per share offers value or just reflects past enthusiasm, the starting point is to separate price moves from underlying worth. The stock is up about 2% over the past week, but remains down around 5.2% over the past month and has fallen about 23.6% year to date and 41.6% over the last 12 months, which can change how investors view both upside potential and risk. Recent coverage has focused on how software and technology companies...
NYSE:CDRE
NYSE:CDREAerospace & Defense

Cadre Holdings (CDRE) Valuation Check After FBI Armor Contract Win

FBI armor contract puts Cadre Holdings (CDRE) in focus Cadre Holdings (CDRE) is back on investor radar after subsidiary Safariland was selected as the ballistic panel provider for Predictive Ballistics' Overt Armor Kit under a five year, $61 million FBI contract. See our latest analysis for Cadre Holdings. Despite the FBI contract putting fresh attention on the business, Cadre Holdings’ share price is down 31% over the past 90 days and 27% year to date. However, the 3 year total shareholder...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

DocuSign (DOCU) Q1 2027 Margin Compression Challenges Bullish Earnings Growth Narratives

DocuSign (DOCU) has kicked off Q1 2027 with total revenue of US$830.2 million and basic EPS of US$0.40, setting the stage for investors to reassess how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$763.7 million in Q1 2026 to US$830.2 million in Q1 2027, while basic EPS shifted from US$0.35 to US$0.40 over the same stretch, giving you a clear read on how sales and earnings are tracking into the new fiscal year as margins come under...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox Faces Legal Scrutiny As Discovery Shift Reshapes Long Term Story

A law firm has opened an investigation into Roblox (NYSE:RBLX) over potential fraud, negligence, or other unlawful practices, raising fresh questions about governance and legal risk for the platform. Separately, Roblox is overhauling its discovery algorithm to emphasize deeper user engagement and long term retention instead of immediate monetization. The company is aiming to improve content quality and appeal more to adult users. Roblox runs a global user generated gaming and experiences...
NasdaqGS:LAES
NasdaqGS:LAESSemiconductor

SEALSQ Pursues Quantum Platform Ambition As Shares Lag Analyst Target

Over the past week, SEALSQ (NasdaqGS:LAES) has announced a majority stake in Wecan Group, the acquisition of Swiss photonics firm Miraex, and a lead investment role in EeroQ and Quobly funding rounds. These moves extend SEALSQ's reach across post quantum security, quantum processors, and AI driven compliance tools in both Europe and the US. The transactions are presented as completing SEALSQ's Quantum Sovereign Vertical Stack and shifting the company toward a broader quantum platform...
NYSE:KEY
NYSE:KEYBanks

Has The Strong 1 Year Rally Left KeyCorp (KEY) Fully Priced Or Still Attractive?

Wondering if KeyCorp's share price still reflects good value after a strong run, or if most of the easy gains are behind it? This article walks through what the current valuation actually says. KeyCorp shares last closed at US$21.76, with the stock up 2.0% over the past week, slightly down 2.1% over the past month, up 3.7% year to date, and up 38.9% over the past year, while the 3 year and 5 year returns stand at 137.8% and 26.4% respectively. Recent price moves sit against a backdrop of...
NYSE:ADCT
NYSE:ADCTBiotechs

Assessing ADC Therapeutics (ADCT) Valuation After Pivotal LOTIS-5 Phase 3 ZYNLONTA Trial Results

ADC Therapeutics (ADCT) has drawn fresh attention after reporting statistically significant Phase 3 LOTIS-5 topline data for ZYNLONTA plus rituximab in relapsed or refractory diffuse large B cell lymphoma, including improved progression free survival versus standard therapy. See our latest analysis for ADC Therapeutics. Despite the encouraging LOTIS-5 data, the stock’s 1-day share price return fell 21.97%, extending a 7-day share price decline of 69.71% and a 1-year total shareholder return...
NYSE:BIPC
NYSE:BIPCGas Utilities

Is Brookfield Infrastructure (BIPC) Pricing In Too Much Growth After Recent Share Price Rebound

For investors wondering whether Brookfield Infrastructure at around US$41.31 offers value or is asking too much for its future, this breakdown is designed to help frame that question in a clear, practical way. The stock has been slightly softer over the last week, with a 0.5% decline, but has gained 4.6% over the past month. Year to date it is down 8.8% and it is up 5.7% over the last year, with a 2.1% decline over three years and a 7.3% gain over five years. Recent price moves sit against a...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

Aurinia Data At EULAR 2026 And Insider Buys Shape LUPKYNIS Outlook

Aurinia Pharmaceuticals (NasdaqGM:AUPH) reported new AURORA 1 Phase 3 data at EULAR 2026 showing LUPKYNIS reduced the risk of renal events or death in lupus nephritis. The findings were presented at a major international rheumatology congress, putting fresh clinical evidence for LUPKYNIS in front of global specialists. Tang Capital Management increased its stake in Aurinia, and senior company executives acquired additional shares. Aurinia focuses on therapies for autoimmune kidney disease,...